You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

List of Excipients in API calcipotriene, betamethasone dipropionate


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing calcipotriene, betamethasone dipropionate

Detailed excipient profiles for calcipotriene, betamethasone dipropionate

Excipient focus: .ALPHA.-TOCOPHEROL, DL-

calcipotriene, betamethasone dipropionate drug variants containing .ALPHA.-TOCOPHEROL, DL-

calcipotriene, betamethasone dipropionate drug variants not containing .ALPHA.-TOCOPHEROL, DL-

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: MINERAL OIL

calcipotriene, betamethasone dipropionate drug variants containing MINERAL OIL

Excipient focus: PETROLATUM

calcipotriene, betamethasone dipropionate drug variants containing PETROLATUM

Excipient focus: POLYPROPYLENE GLYCOL 15 STEARYL ETHER

calcipotriene, betamethasone dipropionate drug variants not containing POLYPROPYLENE GLYCOL 15 STEARYL ETHER

Excipient focus: PPG-15 STEARYL ETHER

calcipotriene, betamethasone dipropionate drug variants containing PPG-15 STEARYL ETHER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group